Mankind Pharma Board Approves Q2 Financial Results, Net Profit Reaches ₹520 Crore
Mankind Pharma’s board has approved the unaudited financial results for the second quarter (Q2) of FY26. The company reported a…
GlaxoSmithKline Solar Power Investment & Q2 2025 Financial Results
GlaxoSmithKline Pharmaceuticals has approved an investment of ₹1.74 crores in a solar power project for its Nashik plant, utilizing a group…
Welspun Corp Q2 & H1 FY26 Earnings Call Transcript
Welspun Corp has announced the availability of the transcript for its Q2 & H1 FY26 earnings call held on October 31, 2025. The transcript…
NTPC Limited Q2 FY26 Earnings Conference Call Transcript Highlights
NTPC Limited reported a strong performance in Q2 FY26, with capacity increasing to 83893 MW. The company added 4403 MW in H1 FY26, the highest…
Mankind Pharma Revenue Jumps 20.8% with Strong Q2 FY26 Performance
Mankind Pharma announced a 20.8% increase in revenue for Q2 FY26, driven by strong performance in chronic and BSV consolidation. Revenue…
NHPC Limited Board Approves Unaudited Financial Results for Q2 2025-26
The Board of Directors of NHPC Limited has approved the unaudited standalone and consolidated financial results for the quarter and half-year…
Mankind Pharma Investor Presentation on Q2 FY26 Financial Results
Mankind Pharma has released its investor presentation for the second quarter of fiscal year 2026. Revenue grew by 20.8%, driven by…
HUDCO Key Managerial Personnel Changes Announced
HUDCO announced that Shri LVS Sudhakar Babu, ED(Finance), has been relieved from the services of HUDCO due to his appointment as Managing…
Triveni Engineering Board Approves Q2 FY26 Financial Results
Triveni Engineering & Industries Ltd. announced the approval of its unaudited standalone and consolidated financial results for the…
GlaxoSmithKline Approves Solar Project and Q2 2025 Financial Results
GlaxoSmithKline Pharmaceuticals Limited (GSK) has approved an investment of ₹1.74 crores for a solar power project at its Nashik plant under a…